Peter S. Conti
Direttore/Membro del Consiglio presso FluoroPharma, Inc.
Profilo
Peter S.
Conti is currently a Director at FluoroPharma, Inc. and AZTherapies, Inc. He is also a Director at NanoTomer, Inc. and a Professor at the University of Southern California.
Previously, he was the Director of Molecular Imaging Corp.
from 2002 to 2008.
He also served as an Independent Director at FluoroPharma Medical, Inc. and as the President of the Society of Nuclear Medicine & Molecular Imaging.
Conti earned a doctorate degree from Cornell University.
Posizioni attive di Peter S. Conti
| Società | Posizione | Inizio |
|---|---|---|
FluoroPharma, Inc.
 FluoroPharma, Inc. Medical SpecialtiesHealth Technology FluoroPharma, Inc. manufactures diagnostic imaging products. It engages in the discovery, development and commercialization of proprietary diagnostic imaging products. The company was founded by David R. Elmaleh in 2003 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 01/01/1991 |
| USC Pet Imaging Science Center | Direttore/Membro del Consiglio | 01/01/1991 |
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
NanoTomer, Inc.
 NanoTomer, Inc. Miscellaneous Commercial ServicesCommercial Services NanoTomer, Inc. provides bio technology services. The company is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Peter S. Conti
| Società | Posizione | Fine |
|---|---|---|
Molecular Imaging Corp.
 Molecular Imaging Corp. Medical/Nursing ServicesHealth Services Molecular Imaging Corp. provides molecular imaging services to the healthcare industry. It is a diagnostic imaging procedure used to diagnose, monitor and assess disease severity for many cancers, cardiovascular disease and neurological disorders. The firm's procedures display metabolic and functional characteristics of disease, which typically are the first indications of disease. It also provides a newer combined MI/CT system. The company was founded by Paul J. Crowe on August 21, 1985 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 04/12/2008 |
| FLUOROPHARMA MEDICAL, INC. | Direttore/Membro del Consiglio | - |
Society of Nuclear Medicine & Molecular Imaging
 Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services The Society of Nuclear Medicine & Molecular Imaging is a non-profit organization that promotes the science, technology, and practical application of nuclear medicine and molecular imaging. The private company is based in Reston, VA. | Presidente | - |
Formazione di Peter S. Conti
| Cornell University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| FLUOROPHARMA MEDICAL, INC. | Commercial Services |
| Aziende private | 6 |
|---|---|
Molecular Imaging Corp.
Molecular Imaging Corp. Medical/Nursing ServicesHealth Services Molecular Imaging Corp. provides molecular imaging services to the healthcare industry. It is a diagnostic imaging procedure used to diagnose, monitor and assess disease severity for many cancers, cardiovascular disease and neurological disorders. The firm's procedures display metabolic and functional characteristics of disease, which typically are the first indications of disease. It also provides a newer combined MI/CT system. The company was founded by Paul J. Crowe on August 21, 1985 and is headquartered in San Diego, CA. | Health Services |
FluoroPharma, Inc.
FluoroPharma, Inc. Medical SpecialtiesHealth Technology FluoroPharma, Inc. manufactures diagnostic imaging products. It engages in the discovery, development and commercialization of proprietary diagnostic imaging products. The company was founded by David R. Elmaleh in 2003 and is headquartered in Boston, MA. | Health Technology |
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Health Technology |
| USC Pet Imaging Science Center | |
Society of Nuclear Medicine & Molecular Imaging
Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services The Society of Nuclear Medicine & Molecular Imaging is a non-profit organization that promotes the science, technology, and practical application of nuclear medicine and molecular imaging. The private company is based in Reston, VA. | Commercial Services |
NanoTomer, Inc.
NanoTomer, Inc. Miscellaneous Commercial ServicesCommercial Services NanoTomer, Inc. provides bio technology services. The company is headquartered in Boston, MA. | Commercial Services |
- Borsa valori
- Insiders
- Peter S. Conti
